About: Individual risk assessment for intracranial haemorrhage during thrombolytic therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Individual risk assessment for intracranial haemorrhage during thrombolytic therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1993 (uk) article scientifique publié en 1993 (fr) im Dezember 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1993 (ast) scientific article published on 01 December 1993 (en)
publication date	wds:Q72659872-9A6E25A6-9EB5-4074-AAE8-EF6D824185F8
publication date	1993-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72659872-77CA765C-82CF-451A-9D1C-6BE643781806
language of work or name	English
cites work	wds:Q72659872-0AE3B56C-6145-4912-A9A8-A47489E9ACB1 wds:Q72659872-0C6A6057-168A-4334-8632-A11B0839C52D wds:Q72659872-11F92CB5-1B6D-4984-9FC2-9F92BD067EC4 wds:Q72659872-14B139DE-7A84-49D3-8C50-43D46A53248E wds:Q72659872-14CC95B4-3647-4370-8788-C6D8C538EA14 wds:Q72659872-156BF429-DF32-4EA6-AA2C-0C5AA534C45F wds:Q72659872-1A512A2D-069C-4D7A-A696-B92C7BAEA7B8 wds:Q72659872-3C03359D-CA56-4661-8037-B92E00F4AEDD wds:Q72659872-49E5515A-4435-428C-9CA7-71268A8A3CE0 wds:Q72659872-5602B31D-0242-4FDC-972F-4196E3315AC0 wds:Q72659872-666B1068-FB69-4CDB-A69D-F83DBB30E90B wds:Q72659872-7100B4C4-B5F6-4753-9412-BB675640B7E1 wds:Q72659872-75FAF5EC-6139-4FCF-950D-3E827451B834 wds:Q72659872-818822EB-93B1-452C-8EDD-737953082F7F wds:Q72659872-8CBE5988-1151-49F0-96BC-3F3BE580B8D3 wds:Q72659872-96578D27-68D7-42AC-A654-015695D412B4 wds:Q72659872-9F441F29-7027-46D0-8682-7901B6A6BF05 wds:Q72659872-A5310E56-79FD-4ECB-AE9A-E97AF803ACC3 wds:Q72659872-AD4F9704-13CA-4ECE-B3E7-50BA8281ECAB wds:Q72659872-B04AD968-B2B6-476B-BE73-B0E92C3D4CCB wds:Q72659872-B3D783BF-ACDC-45C8-BF94-2A44C6B3EFD4 wds:Q72659872-B41350CF-A05B-4225-960E-58F4A504D280 wds:Q72659872-C10B7288-9AC6-4BC8-922C-65854BDA12BA wds:Q72659872-D8B5995F-7F4C-481E-9C32-E6D0ED24FE83 wds:Q72659872-DB14DDB4-F00C-493C-9405-4E471B9E1BA4 wds:Q72659872-DCB84C36-8980-436B-8C50-63C7502FE4E7 wds:Q72659872-EBB4CCD0-FDAE-4BA5-8B39-3A5B7692764F wds:Q72659872-ECC7E6EB-3F4F-443D-AC96-D0A1765F762D
cites work	Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator Epidemiology of stroke Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction Primary prevention of stroke Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction Epidemiology of stroke in Tilburg, the Netherlands. The population-based stroke incidence register: 2. Incidence, initial clinical picture and medical care, and three-week case fatality. Update from the Thrombolysis in Myocardial Infarction Trial The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty Intracerebral haemorrhage Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors
author name string	wds:Q72659872-24BA8C60-1A85-4928-88D7-91A1266EC3D4 wds:Q72659872-4C57FAB5-CAA2-4680-9AFE-7DF020E400B5 wds:Q72659872-5003A4E3-45F5-4AD8-9D39-53F6A125D01E wds:Q72659872-BA4715AB-CF3E-4300-99D7-A6B311964C6E wds:Q72659872-C3A17E3B-7816-4B14-959F-F0CFB13FCF3B wds:Q72659872-C846CEEB-82C7-405A-9BB2-CCF84479D0D8 wds:Q72659872-CFA12E73-6A71-45FD-91DF-B6D26911C105 wds:Q72659872-DE14DF29-05C1-4BFD-AAD3-514FEE6606D3
author name string	M L Simoons E Boersma M G Franzosi R van Domburg R Schröder P de Jaegere G Knatterud J D Leimberger
rdfs:label	Individual risk assessment for intracranial haemorrhage during thrombolytic therapy (en) Individual risk assessment for intracranial haemorrhage during thrombolytic therapy (nl)
skos:prefLabel	Individual risk assessment for intracranial haemorrhage during thrombolytic therapy (en) Individual risk assessment for intracranial haemorrhage during thrombolytic therapy (nl)
name	Individual risk assessment for intracranial haemorrhage during thrombolytic therapy (en) Individual risk assessment for intracranial haemorrhage during thrombolytic therapy (nl)
author	wds:Q72659872-705C90D4-CD61-46F6-B16C-1A1C501178B9 wds:Q72659872-EA8B164C-653D-4356-BE15-840BFE43D7DC
author	Robert Califf Aldo P. Maggioni
title	wds:Q72659872-6BD37520-FA94-4E6C-994B-077E6737FDE0
title	Individual risk assessment for intracranial haemorrhage during thrombolytic therapy (en)
page(s)	wds:Q72659872-2B96FD07-EA8F-4577-8856-F55DA2DD4040
page(s)	1523-1528
instance of	wds:Q72659872-7F08B444-7E8F-4EC3-92E3-371C2FC7C36C
instance of	scholarly article
main subject	wds:Q72659872-4B779879-659E-4184-BA0D-D9AF4892C392

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software